ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart cancer therapy: tailoring lung cancer treatment with a simple blood test
Disease control Not yet recruitingThis trial investigates a personalized approach for people with advanced EGFR-mutant non-small cell lung cancer who have not had prior treatment. Participants first take the targeted pill befotertinib for three weeks, then a blood test checks for minimal residual disease (MRD). T…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a common antioxidant boost chemo for advanced lung cancer?
Disease control Not yet recruitingThis study tests whether adding alpha lipoic acid (a strong antioxidant) to standard chemotherapy helps people with advanced non-small cell lung cancer. About 60 adults with stage III or IV lung cancer will take 600 mg of alpha lipoic acid daily alongside their chemo. Researchers…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Timing is everything: new trial seeks to boost lung cancer treatment by rescheduling immunotherapy
Disease control Not yet recruitingThis clinical trial is testing whether giving immunotherapy a few days after chemotherapy, instead of on the same day, can improve outcomes for people with advanced non-small cell lung cancer. The study will enroll 246 adults and compare three different timing schedules, includin…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC